Preparation and characterization of specific antisera to individual glycoprotein antigens comprising the major glycoprotein region of herpes simplex virus type 1.
about
Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cellsMolecular cloning and analysis of three cDNA clones homologous to human cytomegalovirus RNAs present during late infection.Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virusMonoclonal antibodies to two glycoproteins of herpes simplex virus type 2.Identification, transfer, and characterization of cloned herpes simplex virus invasiveness regionsDifferential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells.Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.Cell-mediated immunity to herpes simplex virus: recognition of type-specific and type-common surface antigens by cytotoxic T cell populationsAssay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human seragA and gB glycoproteins of herpes simplex virus type 1: two forms of a single polypeptide.Secondary herpes simplex virus latent infection in transplanted ganglia.Orientation of the cleavage site of the herpes simplex virus glycoprotein G-2.Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein B.Differential rates of processing and transport of herpes simplex virus type 1 glycoproteins gB and gC.Identification and characterization of the herpes simplex virus type 1 virion protein encoded by the UL35 open reading frame.The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).A major transcriptional regulatory protein (ICP4) of herpes simplex virus type 1 is associated with purified virions.Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetrationCharacterization and mapping of a nonessential pseudorabies virus glycoprotein.Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibodyThe cytoplasmic domain of herpes simplex virus type 1 glycoprotein C is required for membrane anchoring.Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteinsInducible expression of herpes simplex virus type 2 glycoprotein gene gG-2 in a mammalian cell line.Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.Processing of the herpes simplex virus type 2 glycoprotein gG-2 results in secretion of a 34,000-Mr cleavage product.Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteinsEvidence for post-translational glycosylation of a nonglycosylated precursor protein of herpes simplex virus type 1.Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sitesGlycosylation of herpes simplex virus type 1 gC in the presence of tunicamycinPhysical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assayCharacterization of a herpes simplex virus type 2 75,000-molecular-weight glycoprotein antigenically related to herpes simplex virus type 1 glycoprotein CGenetic and phenotypic analysis of herpes simplex virus type 1 mutants conditionally resistant to immune cytolysisVirus-specific glycoproteins associated with the nuclear fraction of herpes simplex virus type 1-infected cellsMapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytesCharacterization of the major mRNAs transcribed from the genes for glycoprotein B and DNA-binding protein ICP8 of herpes simplex virus type 1.Replication of simian herpesvirus SA8 and identification of viral polypeptides in infected cells.Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.Detection of herpes simplex virus type 2 glycoproteins expressed in virus-transformed rat cells
P2860
Q33910508-6B43CC4F-5366-4232-A6C3-FEF033906B78Q33927905-8665B791-EE66-46B9-9FB2-A730490F4034Q34340404-35B3DC1B-EBD3-4994-B2A2-0B78CA838D08Q34605155-437A9411-1516-4DFD-AE45-1D7D99D59527Q35242073-8DFBBC6E-0C08-4AF3-B7D1-042CA8D37511Q35391149-9F25313A-F933-4490-A735-6A21D0003832Q35469980-9C8773CE-55A3-44D1-9299-AFC3BBF0CA91Q36335255-4E335E32-69B2-4821-AF25-358C53A93F1DQ36431930-945F0FDD-0264-4D43-B252-99380B7F1ED3Q36444916-5FCF32B9-D31E-4ACE-8D8A-A29670884CB9Q36508282-4C552A5B-03B5-4EB9-882D-E52EE9D41DD8Q36637025-451F6E6A-8ADF-4C11-8834-029A84E11719Q36646404-6AAA166F-60CD-45F4-9C7A-96E4F0D8F091Q36683642-27F455A3-20D1-495D-8A7C-394891C5D6E0Q36688245-57FA3550-158A-45A6-A6C8-B2CE685F6B2EQ36696803-1EC67F1B-BF12-47DA-821D-08AECEC9F914Q36783279-BAB20DA0-F444-42C0-A37E-6E8BD51E594FQ36829808-0148CBE9-7A82-494F-9214-2C4451C8A917Q36829924-5453F688-C52B-44F8-A3C0-D1B77ACFC076Q36861204-5BEC85C1-620E-4420-9B5A-CD9050A1429DQ36861859-6FFE51E6-FD5F-44C2-9580-71574BB6B621Q36867252-0F3EA6F2-6907-4BC5-8F96-0375B7A721B8Q36871442-5A18A681-B364-451F-BE73-EB8BB7500FF5Q36872956-0E97B76A-79DD-4B32-A5DF-4D123BEE354CQ36884762-26554242-761B-415C-A5AD-B815850642BCQ36888324-A746DB37-6342-42D9-8780-5F3711479779Q36895826-26D42862-1CE3-4E9E-BA14-664DD043A46DQ36895940-D6CC9583-138A-405C-9F9D-41FC76F373F2Q36903456-60FFD652-A960-4508-AC41-4BFB05DAE15EQ36903869-DEDAAB1C-7CC9-4C9F-A223-058755790F50Q36905528-6029A99F-27AC-4271-B784-1224FB425532Q36906452-234485F9-7707-48F2-8D7A-2A8912F8E421Q36907968-5238521A-7D32-4B24-8ECA-33435D9A644BQ36908014-AC29B199-FA9C-4E59-A025-CD442545D2F0Q36912380-BDB7484D-5131-4330-B712-8A0C2896A256Q36912992-C718E639-0C42-49C4-AC3B-2F8B90980184Q36913501-DDE6CA03-5A20-4D68-9E1D-26134B12871BQ36914986-3DA045D6-567D-4730-A32C-2CBADC649060Q36917531-1E48A70F-6744-41B1-BFC9-5C0CD00AB306Q36921439-43E7C584-35E9-4459-899D-254BCCCA9AA3
P2860
Preparation and characterization of specific antisera to individual glycoprotein antigens comprising the major glycoprotein region of herpes simplex virus type 1.
description
1980 nî lūn-bûn
@nan
1980 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
name
Preparation and characterizati ...... f herpes simplex virus type 1.
@ast
Preparation and characterizati ...... f herpes simplex virus type 1.
@en
type
label
Preparation and characterizati ...... f herpes simplex virus type 1.
@ast
Preparation and characterizati ...... f herpes simplex virus type 1.
@en
prefLabel
Preparation and characterizati ...... f herpes simplex virus type 1.
@ast
Preparation and characterizati ...... f herpes simplex virus type 1.
@en
P2860
P1433
P1476
Preparation and characterizati ...... f herpes simplex virus type 1.
@en
P2093
R J Courtney
P2860
P304
P407
P577
1980-09-01T00:00:00Z